Cryocell International Stock Shares Outstanding

CCEL Stock  USD 8.67  0.42  4.62%   
CryoCell International fundamentals help investors to digest information that contributes to CryoCell International's financial success or failures. It also enables traders to predict the movement of CryoCell Stock. The fundamental analysis module provides a way to measure CryoCell International's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CryoCell International stock.
Common Stock Shares Outstanding is expected to rise to about 7.8 M this year.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

CryoCell International Company Shares Outstanding Analysis

CryoCell International's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current CryoCell International Shares Outstanding

    
  8.06 M  
Most of CryoCell International's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CryoCell International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

CryoCell Shares Outstanding Driver Correlations

Understanding the fundamental principles of building solid financial models for CryoCell International is extremely important. It helps to project a fair market value of CryoCell Stock properly, considering its historical fundamentals such as Shares Outstanding. Since CryoCell International's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CryoCell International's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CryoCell International's interrelated accounts and indicators.
0.10.57-0.030.740.880.970.320.50.61-0.270.870.720.810.67-0.07-0.590.91-0.320.350.630.7-0.490.78
0.1-0.450.78-0.42-0.28-0.13-0.050.60.08-0.38-0.08-0.2-0.02-0.260.330.260.080.240.49-0.010.48-0.04-0.02
0.57-0.45-0.280.690.570.670.020.00.30.010.530.660.750.33-0.1-0.810.51-0.22-0.020.350.21-0.370.58
-0.030.78-0.28-0.44-0.35-0.21-0.070.290.25-0.5-0.19-0.13-0.12-0.46-0.020.20.07-0.040.050.170.280.12-0.12
0.74-0.420.69-0.440.780.85-0.010.00.140.020.70.530.820.51-0.2-0.680.61-0.310.050.230.07-0.630.83
0.88-0.280.57-0.350.780.940.460.210.64-0.120.840.690.650.79-0.23-0.490.85-0.330.190.690.53-0.320.65
0.97-0.130.67-0.210.850.940.320.350.57-0.180.880.750.820.72-0.14-0.650.89-0.360.240.620.57-0.490.8
0.32-0.050.02-0.07-0.010.460.320.110.680.040.350.47-0.190.5-0.170.130.45-0.280.140.690.530.63-0.1
0.50.60.00.290.00.210.350.110.35-0.360.420.440.290.340.02-0.360.39-0.10.230.270.78-0.320.27
0.610.080.30.250.140.640.570.680.35-0.30.570.650.160.56-0.34-0.180.75-0.460.00.970.770.180.14
-0.27-0.380.01-0.50.02-0.12-0.180.04-0.36-0.3-0.2-0.14-0.19-0.020.170.13-0.310.250.01-0.24-0.340.19-0.18
0.87-0.080.53-0.190.70.840.880.350.420.57-0.20.810.670.87-0.15-0.540.93-0.340.290.520.59-0.430.78
0.72-0.20.66-0.130.530.690.750.470.440.65-0.140.810.490.7-0.27-0.740.78-0.4-0.010.620.59-0.170.54
0.81-0.020.75-0.120.820.650.82-0.190.290.16-0.190.670.490.350.08-0.740.64-0.060.330.190.33-0.760.89
0.67-0.260.33-0.460.510.790.720.50.340.56-0.020.870.70.35-0.19-0.310.74-0.370.180.520.54-0.210.45
-0.070.33-0.1-0.02-0.2-0.23-0.14-0.170.02-0.340.17-0.15-0.270.08-0.190.2-0.140.620.73-0.360.05-0.020.05
-0.590.26-0.810.2-0.68-0.49-0.650.13-0.36-0.180.13-0.54-0.74-0.74-0.310.2-0.460.170.12-0.21-0.260.59-0.64
0.910.080.510.070.610.850.890.450.390.75-0.310.930.780.640.74-0.14-0.46-0.330.330.710.7-0.30.72
-0.320.24-0.22-0.04-0.31-0.33-0.36-0.28-0.1-0.460.25-0.34-0.4-0.06-0.370.620.17-0.330.53-0.49-0.150.03-0.07
0.350.49-0.020.050.050.190.240.140.230.00.010.29-0.010.330.180.730.120.330.53-0.050.42-0.110.34
0.63-0.010.350.170.230.690.620.690.270.97-0.240.520.620.190.52-0.36-0.210.71-0.49-0.050.70.180.15
0.70.480.210.280.070.530.570.530.780.77-0.340.590.590.330.540.05-0.260.7-0.150.420.7-0.040.27
-0.49-0.04-0.370.12-0.63-0.32-0.490.63-0.320.180.19-0.43-0.17-0.76-0.21-0.020.59-0.30.03-0.110.18-0.04-0.69
0.78-0.020.58-0.120.830.650.8-0.10.270.14-0.180.780.540.890.450.05-0.640.72-0.070.340.150.27-0.69
Click cells to compare fundamentals

CryoCell Shares Outstanding Historical Pattern

Today, most investors in CryoCell International Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CryoCell International's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of CryoCell International shares outstanding as a starting point in their analysis.
   CryoCell International Shares Outstanding   
       Timeline  
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

CryoCell Common Stock Shares Outstanding

Common Stock Shares Outstanding

7.85 Million

At this time, CryoCell International's Common Stock Shares Outstanding is quite stable compared to the past year.
Based on the latest financial disclosure, CryoCell International has 8.06 M of shares currently outstending. This is 95.53% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 98.59% higher than that of the company.

CryoCell Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CryoCell International's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CryoCell International could also be used in its relative valuation, which is a method of valuing CryoCell International by comparing valuation metrics of similar companies.
CryoCell International is currently under evaluation in shares outstanding category among its peers.

CryoCell International ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, CryoCell International's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to CryoCell International's managers, analysts, and investors.
Environmental
Governance
Social

CryoCell Fundamentals

About CryoCell International Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze CryoCell International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CryoCell International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CryoCell International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether CryoCell International is a strong investment it is important to analyze CryoCell International's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CryoCell International's future performance. For an informed investment choice regarding CryoCell Stock, refer to the following important reports:
Check out CryoCell International Piotroski F Score and CryoCell International Altman Z Score analysis.
For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.625
Earnings Share
(1.07)
Revenue Per Share
3.89
Quarterly Revenue Growth
0.025
Return On Assets
(0)
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.